Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sulfonylquinolines as central nervous system and cardiovascular agents

Sulfonylquinolines as central nervous system and cardiovascular agents

US Patent 5552411 · Granted Sep 3, 1996

Estimated economic value: $83,857,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Haloaryl substituted aminopurines, compositions thereof, and methods of treatmen2012
Haloaryl substituted aminopurines, compositions thereof, and methods of treatmen2010
Methods for treating or preventing metastatic cancer using benzopyranone compoun2009
Haloaryl substituted aminopurines, compositions thereof, and methods of treatmen2009
Methods for treating or preventing cancer using Benzopyranone Compounds2008
Benzopyranone compounds, compositions thereof, and methods for treating or preve2006
Benzoxazinoes/benzothiazinones as serine protease inhibitors2003
4-substituted piperidine analogs and their use as subtype selective NMDA recepto2002
4-Benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selecti2001
4-substituted piperidine analogs and their use as subtype selective NMDA recepto2000
Benzimidazoles and imidazopyridines as central nervous system agents1996
Benzimidazoles and imidazopyridines as central nervous system agents1996